C146H198F7N33O17S — CID 167620938
N-[(2R,3S)-3-[4-[[(2S)-2-cycloheptyl-2-[[2,2-difluoro-2-(6-methoxy-3-pyridinyl)acetyl]amino]acetyl]amino]-3-fluorophenyl]-1-(4-methylpiperazin-1-yl)-1-oxobutan-2-yl]thiadiazole-5-carboxamide;N-[(1S)-1-cycloheptyl-2-[2-fluoro-4-[(2S,3R)-3-[(1-fluorocyclopropanecarbonyl)amino]-4-(4-methylpiperazin-1-yl)-4-oxobutan-2-yl]anilino]-2-oxoethyl]-2-ethylpyrazole-3-carboxamide;2-(cyclopropylmethyl)-N-[(2R,3S)-3-[3-fluoro-4-[[(2S)-2-(4-methylcyclohexyl)-2-[(2-propan-2-ylpyrazole-3-carbonyl)amino]acetyl]amino]phenyl]-1-(4-methylpiperazin-1-yl)-1-oxobutan-2-yl]pyrazole-3-carboxamide;N-[(1S)-2-[2-fluoro-4-[(2S,3R)-4-(4-methylpiperazin-1-yl)-4-oxo-3-[(2-propan-2-ylpyrazole-3-carbonyl)amino]butan-2-yl]anilino]-1-(4-methylcyclohexyl)-2-oxoethyl]-2-propan-2-ylpyrazole-3-carboxamide (PubChem CID 167620938) has the molecular formula C146H198F7N33O17S and a molecular weight of 2852.46 g/mol. Its IUPAC name is N-[(2R,3S)-3-[4-[[(2S)-2-cycloheptyl-2-[[2,2-difluoro-2-(6-methoxy-3-pyridinyl)acetyl]amino]acetyl]amino]-3-fluorophenyl]-1-(4-methylpiperazin-1-yl)-1-oxobutan-2-yl]thiadiazole-5-carboxamide;N-[(1S)-1-cycloheptyl-2-[2-fluoro-4-[(2S,3R)-3-[(1-fluorocyclopropanecarbonyl)amino]-4-(4-methylpiperazin-1-yl)-4-oxobutan-2-yl]anilino]-2-oxoethyl]-2-ethylpyrazole-3-carboxamide;2-(cyclopropylmethyl)-N-[(2R,3S)-3-[3-fluoro-4-[[(2S)-2-(4-methylcyclohexyl)-2-[(2-propan-2-ylpyrazole-3-carbonyl)amino]acetyl]amino]phenyl]-1-(4-methylpiperazin-1-yl)-1-oxobutan-2-yl]pyrazole-3-carboxamide;N-[(1S)-2-[2-fluoro-4-[(2S,3R)-4-(4-methylpiperazin-1-yl)-4-oxo-3-[(2-propan-2-ylpyrazole-3-carbonyl)amino]butan-2-yl]anilino]-1-(4-methylcyclohexyl)-2-oxoethyl]-2-propan-2-ylpyrazole-3-carboxamide.
| Compound Name | N-[(2R,3S)-3-[4-[[(2S)-2-cycloheptyl-2-[[2,2-difluoro-2-(6-methoxy-3-pyridinyl)acetyl]amino]acetyl]amino]-3-fluorophenyl]-1-(4-methylpiperazin-1-yl)-1-oxobutan-2-yl]thiadiazole-5-carboxamide;N-[(1S)-1-cycloheptyl-2-[2-fluoro-4-[(2S,3R)-3-[(1-fluorocyclopropanecarbonyl)amino]-4-(4-methylpiperazin-1-yl)-4-oxobutan-2-yl]anilino]-2-oxoethyl]-2-ethylpyrazole-3-carboxamide;2-(cyclopropylmethyl)-N-[(2R,3S)-3-[3-fluoro-4-[[(2S)-2-(4-methylcyclohexyl)-2-[(2-propan-2-ylpyrazole-3-carbonyl)amino]acetyl]amino]phenyl]-1-(4-methylpiperazin-1-yl)-1-oxobutan-2-yl]pyrazole-3-carboxamide;N-[(1S)-2-[2-fluoro-4-[(2S,3R)-4-(4-methylpiperazin-1-yl)-4-oxo-3-[(2-propan-2-ylpyrazole-3-carbonyl)amino]butan-2-yl]anilino]-1-(4-methylcyclohexyl)-2-oxoethyl]-2-propan-2-ylpyrazole-3-carboxamide |
|---|---|
| PubChem CID | 167620938 |
| Molecular Formula | C146H198F7N33O17S |
| Molecular Weight | 2852.46 g/mol |
| Exact Mass | 2850.53 |
| IUPAC Name | N-[(2R,3S)-3-[4-[[(2S)-2-cycloheptyl-2-[[2,2-difluoro-2-(6-methoxy-3-pyridinyl)acetyl]amino]acetyl]amino]-3-fluorophenyl]-1-(4-methylpiperazin-1-yl)-1-oxobutan-2-yl]thiadiazole-5-carboxamide;N-[(1S)-1-cycloheptyl-2-[2-fluoro-4-[(2S,3R)-3-[(1-fluorocyclopropanecarbonyl)amino]-4-(4-methylpiperazin-1-yl)-4-oxobutan-2-yl]anilino]-2-oxoethyl]-2-ethylpyrazole-3-carboxamide;2-(cyclopropylmethyl)-N-[(2R,3S)-3-[3-fluoro-4-[[(2S)-2-(4-methylcyclohexyl)-2-[(2-propan-2-ylpyrazole-3-carbonyl)amino]acetyl]amino]phenyl]-1-(4-methylpiperazin-1-yl)-1-oxobutan-2-yl]pyrazole-3-carboxamide;N-[(1S)-2-[2-fluoro-4-[(2S,3R)-4-(4-methylpiperazin-1-yl)-4-oxo-3-[(2-propan-2-ylpyrazole-3-carbonyl)amino]butan-2-yl]anilino]-1-(4-methylcyclohexyl)-2-oxoethyl]-2-propan-2-ylpyrazole-3-carboxamide |
| SMILES | CC1CCC([C@H](NC(=O)c2ccnn2C(C)C)C(=O)Nc2ccc([C@H](C)[C@@H](NC(=O)c3ccnn3C(C)C)C(=O)N3CCN(C)CC3)cc2F)CC1.CC1CCC([C@H](NC(=O)c2ccnn2C(C)C)C(=O)Nc2ccc([C@H](C)[C@@H](NC(=O)c3ccnn3CC3CC3)C(=O)N3CCN(C)CC3)cc2F)CC1.CCn1nccc1C(=O)N[C@H](C(=O)Nc1ccc([C@H](C)[C@@H](NC(=O)C2(F)CC2)C(=O)N2CCN(C)CC2)cc1F)C1CCCCCC1.COc1ccc(C(F)(F)C(=O)N[C@H](C(=O)Nc2ccc([C@H](C)[C@@H](NC(=O)c3cnns3)C(=O)N3CCN(C)CC3)cc2F)C2CCCCCC2)cn1 |
| InChI | InChI=1S/C39H54FN9O4.C38H54FN9O4.C35H43F3N8O5S.C34H47F2N7O4/c1-24(2)49-33(15-17-42-49)37(51)45-35(28-10-6-25(3)7-11-28)38(52)43-31-13-12-29(22-30(31)40)26(4)34(39(53)47-20-18-46(5)19-21-47)44-36(50)32-14-16-41-48(32)23-27-8-9-27;1-23(2)47-31(14-16-40-47)35(49)43-33(38(52)46-20-18-45(7)19-21-46)26(6)28-12-13-30(29(39)22-28)42-37(51)34(27-10-8-25(5)9-11-27)44-36(50)32-15-17-41-48(32)24(3)4;1-21(29(42-31(47)27-20-40-44-52-27)33(49)46-16-14-45(2)15-17-46)23-10-12-26(25(36)18-23)41-32(48)30(22-8-6-4-5-7-9-22)43-34(50)35(37,38)24-11-13-28(51-3)39-19-24;1-4-43-27(13-16-37-43)30(44)39-29(23-9-7-5-6-8-10-23)31(45)38-26-12-11-24(21-25(26)35)22(2)28(40-33(47)34(36)14-15-34)32(46)42-19-17-41(3)18-20-42/h12-17,22,24-28,34-35H,6-11,18-21,23H2,1-5H3,(H,43,52)(H,44,50)(H,45,51);12-17,22-27,33-34H,8-11,18-21H2,1-7H3,(H,42,51)(H,43,49)(H,44,50);10-13,18-22,29-30H,4-9,14-17H2,1-3H3,(H,41,48)(H,42,47)(H,43,50);11-13,16,21-23,28-29H,4-10,14-15,17-20H2,1-3H3,(H,38,45)(H,39,44)(H,40,47)/t25?,26-,28?,34+,35-;25?,26-,27?,33+,34-;21-,29+,30-;22-,28+,29-/m0000/s1 |
| InChIKey | MKSSTJWMNYJZEG-FKVCKIEQSA-N |
| XLogP | 16.63 |
| TPSA | 580.40 Ų |
| H-Bond Donors | 12 |
| H-Bond Acceptors | 35 |
| Rotatable Bonds | 48 |
| Heavy Atoms | 204 |
| Complexity | — |
4 violations
| Rule | Value |
|---|---|
| MW ≤ 500 | 2852.46 |
| LogP ≤ 5 | 16.63 |
| H-Bond Donors ≤ 5 | 12 |
| H-Bond Acceptors ≤ 10 | 35 |